Systematic review / meta-analysisHuman

Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women

Journal of sex research, 2021 Nov-Dec. Spielmans GI.

Study type

Systematic review / meta-analysis

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Journal of sex research

Published

2021 Nov-Dec

PubMed

PMID 33678061 ↗

DOI

10.1080/00224499.2021.1885601 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

PT-141 →

Indexed under

MeSH terms assigned by the National Library of Medicine.

FemaleHumansLibidoPeptides, CyclicSexual Dysfunctions, Psychologicalalpha-MSH

Other papers on PT-141

Randomized controlled trial · 2019

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

Journal article · 2019

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page